Long-term outcomes of spinal SBRT. Is it important to select the treatment time?
Héctor Pérez-MonteroOscar GodinoAlicia LozanoL AsiáinEva Maria Lozano MartinJuan José SánchezRodolfo de BlasE FernándezMilica StefanovicNagore Garcia-ExpositoJ MartínezFerran GuedeaArturo Navarro-MartinPublished in: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico (2021)
Spine SBRT at our institution showed a 2-year LC of 70.6%, without G3 toxicities. Delaying SBRT at least 6 months to administer systemic treatment was related to an improvement in local control.